These data suggested that histone methylation dysregulation may be associated with the role of KDM6B during tumor pathogenesis, which is consistent with previous studies (Qin et al., 2021; Yildirim-Buharalioglu, 2022). The gene discussed is KDM6B; the disease is neoplasm.